Glenmark gets USFDA final nod for anti-fungal ointment
Glenmark Pharmaceuticals Inc has been granted final approval by the US Food and Drug Administration (USFDA) for nystatin and triamcinolone acetonide ointment.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Food and Drug Administration (FDA) | Nystatin | Pharmaceuticals | Triamcinolone